Nature’s Sunshine Reports Strong Q3 2025 Results
Nature’s Sunshine Products (NATR) reported strong Q3 2025 results, with net sales increasing by 12% to $128.3 million and GAAP earnings per share rising by 30% to $0.30. Adjusted EBITDA surged 42% to $15.2 million, driven by strategic investments in North America Digital, leading to a 52% rise in digital sales. The Asia-Pacific region also saw over 30% growth. The company raised its full-year outlook, projecting net sales between $476 million and $480 million. Nature’s Sunshine maintains a strong balance sheet with $95.6 million in cash and no debt.
Nature’s Sunshine Products ( (NATR) ) has released its Q3 earnings. Here is a breakdown of the information Nature’s Sunshine Products presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Nature’s Sunshine Products, Inc., a prominent player in the natural health and wellness industry, specializes in manufacturing and distributing high-quality herbal and nutritional supplements across more than 40 countries. In its latest earnings report for the third quarter of 2025, the company announced a significant increase in net sales and profitability. Net sales rose by 12% to $128.3 million, while the GAAP earnings per share saw a 30% increase to $0.30. The adjusted EBITDA also experienced a substantial rise of 42%, reaching $15.2 million.
The company’s financial performance was bolstered by strategic investments, particularly in North America Digital, which resulted in a 52% surge in digital sales. Additionally, the Asia-Pacific region showed impressive growth, with over 30% increases in both Japan and China. Cost-saving initiatives further enhanced the gross profit margin, which increased by 200 basis points to 73.3%, marking the highest level in 15 quarters.
Operating income improved to $9.0 million, representing 7.0% of net sales, compared to $5.3 million or 4.6% of net sales in the previous year. The company’s robust cash flow from operating activities reached $25.4 million for the first nine months of 2025, and it maintained a strong balance sheet with $95.6 million in cash and no debt.
Looking ahead, Nature’s Sunshine has raised its full-year outlook, projecting net sales to range between $476 million and $480 million, and adjusted EBITDA to be between $47 million and $49 million. With a focused strategy and a new CEO at the helm, the company is well-positioned to continue its growth trajectory and deliver long-term value to shareholders.
